AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2018

Jan 5, 2018

29777_dirs_2018-01-05_ee3647be-4da4-4261-97d1-d1215e067f1a.zip

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-12-22

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-22	Common shares without par value	G	440	—	Disposed	3086445	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	31675	Indirect
Common shares without par value	9978	Indirect
Common shares without par value	9992	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 3, 2018.

F2: The reporting person disclaims beneficial ownership of all securities held by his son.